A unique approach to targeting the abnormal T-cells that cause T-cell lymphomas could offer hope to patients with the aggressive and difficult-to-treat family of cancers, finds a study involving researchers from Cardiff University. The team of researchers, working with bio-pharmaceutical company Autolus Ltd, have discovered a method of targeting the cancer without destroying healthy T-cells, essential to the immune system. Lymphomas arise when immune cells, called lymphocytes, that protect us against germs, become…
MIAMI: Bone marrow transplants that do not require dangerous and often toxic chemotherapy could soon be possible, US researchers said after seeing initial success with experiments on mice.
CHICAGO: A Novartis trial of two drugs against an aggressive lung cancer bodes well for broadening their use beyond melanoma, the Swiss drugmaker told the American Society of Clinical Oncology's conference in Chicago on Tuesday. Novartis's Tafinlar and Mekinist combination shrank tumors in 63 percent of the trial's 57 people with BRAF V600E-mutation positive non-small cell lung cancer who had failed on chemotherapy, the company said, citing a Phase II study.
It's Mother's Day, which means it's a time to celebrate mothers love and affection around the world — whether that's our friends, our own moms, or celebrity mothers who make us proud.
Singer and actress Selena Gomez said that she was diagnosed auto-immune disease lupus, which led to her cancelling the end of her tour in 2013, but that the disease is now in remission.